M104 peptide
M104 peptide is an OXA-48 carbapenemase inhibitor and antibiotic potentiator. M104 peptide effectively blocks the binding and active site cavity of OXA-48. M104 peptide restores Meropenem (HY-13678)’s antibacterial activity against OXA-48-producing Klebsiella pneumoniae. M104 peptide can be used for the research of Carbapenem-resistant Klebsiella pneumoniae infection.
For research use only. We do not sell to patients.
- Formula: C117H173N29O29S
- Molecular Weight:2481.87
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All Beta-lactamase Isoforms
More
Biological Activity
Description
In Vitro
M104 peptide (7-125 μg/mL; 18 h) reduces the meropenem MIC by 4-fold against a meropenem-resistant, blaOXA-48-harboring Klebsiella pneumoniae strain, restoring intermediate susceptibility to meropenem[1].
Peptide M104 (50-200 μg/mL; 18 h) enhances meropenem's biofilm inhibition activity against strong biofilm-forming blaOXA-48-positive Klebsiella pneumoniae clinical isolates, reducing meropenem MBIC values by two-fold for all 5 tested isolates, though the overall effect is not statistically significant (p-value = 0.06)[2].
Peptide M104 (200 μg/mL; 24-48 h) is non-cytotoxic to HDFa cells after 24 h of incubation, but causes a significant 9.9% reduction in cell viability after 48 h of incubation[2].
Peptide M104 (200 μg/mL; 1 h) exhibits no hemolytic activity against fresh human red blood cells after 1 h of incubation[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Human dermal fibroblast (HDFa) cell line
-
Concentration:200 μg/mL
-
Incubation Time:24 h; 48 h
-
Result:Maintained a mean cell viability of 99.6% in HDFa cells after 24 h of incubation, which was not statistically different from the untreated control (p-value > 0.05).
Reduced mean cell viability significantly to 90.1% after 48 h of incubation compared to the untreated control (p-value < 0.05).
Chemical Information
-
Molecular Weight 2481.87
-
Formula C117H173N29O29S
-
Sequence
Met-Glu-Ala-Phe-Ile-Val-Ser-Ala-Phe-Lys-His-Gln-Ala-Glu-Gly-Phe-Lys-Leu-His-Tyr-Lys
-
Sequence Shortening
MEAFIVSAFKHQAEGFKLHYK
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
-
Bacterial live/dead nucleic-acid viability staining
The LIVE/DEAD bacterial viability staining method is based on differential permeability of nucleic-acid-binding fluorescent dyes, most commonly SYTO 9 and propidium iodide (PI), which enables discrimination of bacterial populations with intact versus compromised cytoplasmic membranes. SYTO 9 penetrates both intact and damaged bacterial membranes and binds nucleic acids to produce green fluorescence, whereas propidium iodide penetrates only cells with compromised membranes and fluoresces red while also reducing SYTO 9 signal through competitive binding and fluorescence interactions. The resulting fluorescence pattern is interpreted as a proxy for membrane integrity, which is widely used as an indicator of bacterial viability in microscopy, flow cytometry, and spectroscopic platforms. However, mechanistic studies show that SYTO 9 and PI interactions involve displacement and fluorescence resonance energy transfer effects, which can influence signal interpretation depending on dye ratios a
Purity & Documentation
References
[1]. Sadeghi S, et al. Design of novel human microbiome-derived peptides for inhibition of OXA-48 Carbapenemase: An in-silico and in-vitro approach. Microb Pathog. 2025;206:107779. [Content Brief]
[2]. Sadeghi S, et al. Enhanced meropenem activity by a microbiome derived peptide targeting oxacillinase 48 carbapenemase in carbapenem resistant Klebsiella pneumoniae isolates. Sci Rep. 2026;16(1):7589. Published 2026 Feb 6. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- M104 peptide
- Beta-lactamase
- Bacterial
- meropenem
- OXA-48 carbapenemase
- carbapenem-resistant klebsiella pneumoniae infection
- HDFa cell
- carbapenem-resistant Klebsiella pneumoniae clinical isolates
- blaOXA-48-harboring Klebsiella pneumoniae strain
- Klebsiella pneumoniae
- biofilm
- fresh human red blood cells
- OXA-48-like carbapenemase
- Inhibitor
- inhibitor
- inhibit